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The Small Colony Variant of Listeria
monocytogenes Is More Tolerant to
Antibiotics and Has Altered Survival
in RAW 264.7 Murine Macrophages
Thomas D. Curtis, Lone Gram* and Gitte M. Knudsen
Gram Lab, Department of Systems Biology, Technical University of Denmark, Kongens Lyngby, Denmark
Small Colony Variant (SCV) cells of bacteria are a slow-growing phenotype that result
from specific defects in the electron transport chain. They form pinpoint colonies on
agar plates and have a variety of phenotypic characteristics, such as altered carbon
metabolism, decreased toxin and lytic enzyme production, aminoglycoside resistance,
and increased intracellular persistence. They are clinically relevant in Staphylococcus
aureus and Pseudomonas aeruginosa, serving as a reservoir for recurrent or prolonged
infections. Here, we found that a SCV mutant in the foodborne pathogen Listeria
monocytogenes (strain SCV E18), similar to the high persister mutant phenotype,
survived significantly better than the wild type when exposed over a 48-h period to
concentrations above Minimal Inhibitory Concentration for most tested antibiotics. SCV
E18 survived more poorly than the wildtype in unactivated RAW264.7 macrophage
cells, presumably because of its reduced listeriolysin O expression, however, it survived
better in reactive oxygen species producing, phorbol 12-myristate 13-acetate-activated
macrophages. Although SCV E18 was sensitive to oxygen as it entered the stationary
phase, it was significantly more tolerant to H2O2 than the wild type, which may result
from a shift in metabolism, however, further investigation is needed to resolve this. SCV
E18 is a spontaneous mutant with a point mutation in the hemA gene. A wild type copy
of hemA was complemented on plasmid pSOG30222, which restored the wild type
phenotype. The results reported here suggest that the SCV of L. monocytogenes could
be of clinical importance and highlight a need for adequate clinical screening for this
phenotype, as it could affect antibiotic treatment outcomes.
Keywords: Listeria monocytogenes, small colony variants, antibiotic tolerance, persister cells, cell invasion,
oxidative stress
INTRODUCTION
Listeria monocytogenes is a Gram-positive, foodborne pathogen that can cause the rare, but
often lethal infection listeriosis. This typically affects pregnant women, neonates, the elderly and
the immunocompromised, and can cause mortality rates of up to 34% (Farber and Peterkin,
1991). Upon entry into the gastrointestinal tract, L. monocytogenes infects host epithelial cells
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and immediately escapes the phagosome where it is free to
replicate within the cytosol. Using actin-mediated mobility
it spreads to neighboring cells and eventually enters the
bloodstream, causing systemic listeriosis if unchecked by the
innate immune system (Portnoy et al., 2002). Macrophages are
a key part of the innate immune response and control the initial
infection by engulfing and killing the bacteria with of a variety of
antimicrobial compounds, such as reactive oxygen and nitrogen
species (Shaughnessy and Swanson, 2007).
Treatment options for listeriosis are limited as many
antibiotics are only bacteriostatic against L. monocytogenes.
Ampicillin is the treatment of choice, and is sometimes
used in combination with gentamicin, although the necessity
of this supplemental treatment has been debated (Temple
and Nahata, 2000; Mitjà et al., 2009). For patients who
cannot tolerate ampicillin, a combination of trimethoprim
and sulfamethoxazole, known as co-trimoxazole (SXT), or
macrolides are substituted. (Temple and Nahata, 2000). While
resistance in L. monocytogenes is uncommon, particularly for the
clinically relevant antibiotics (Morvan et al., 2010), we recently
demonstrated that this bacterium can form multi-antibiotic
tolerant persister cells (Knudsen et al., 2013). However, it is not
known if such cells are formed in vivo during infection, which
could further complicate antibiotic treatment.
Persister cells are a very small subpopulation of bacteria
that enter a dormant-like state making them refractory to
most antibiotics. Their tolerance to antibiotics is not genetically
inherited, and can be operationally defined by a biphasic killing
curve when treated with bactericidal antibiotics and no observed
increase in the Minimum Inhibitory Concentration (MIC)
(Lewis, 2010). Persister cells are thought to exist in all bacteria
and have been linked to recurrent infections with a number
of diseases (Maisonneuve and Gerdes, 2014). Their formation
can be either stochastic and the result of phenotypic switching
from normally growing cells to those with reduced growth
rates (Balaban et al., 2004), or they can be induced by certain
conditions, such as biofilms (Lewis, 2010) or internalization
by macrophages (Helaine et al., 2014). One of the primary
genetic mechanisms of persister formation identified so far are
toxin/antitoxin (TA) modules, which consist of a stable toxin
that slows bacterial growth or metabolism and an unstable
antitoxin that neutralizes the activity of the toxin under growth
conditions. By repeatedly exposing Escherichia coli to high
concentrations of ampicillin, Fridman et al. (2014) found that
bacteria can also tolerate antibiotics by extending the lag-phase
by mutations in a variety of pathways, essentially rendering
the cells dormant until the transient antibiotic pressure is
removed.
Another potential reservoir of persistent and recurrent
bacterial infections is the so-called Small Colony Variant (SCV)
(Kahl et al., 2016). The SCV is a slow growing phenotypic variant
that forms pinpoint colonies when plated on agar, and is the
result of either thymidine auxotrophy caused by mutations in
the thymidylate synthase gene (Besier et al., 2007; Chatterjee
et al., 2008) or an interruption in the electron transport chain
(ETC), specifically resulting from an absence of menadione or
hemin biosynthesis and metabolism. These variants can either be
fixed, which is the result of a mutation in one of the biosynthesis
or metabolism genes for the aforementioned compounds, or
transient, alternating between the wild type and SCV phenotypes
during replication (Edwards, 2012). Additional characteristics
include altered carbon metabolism, reduced toxin and lytic
enzyme production, and resistance to aminoglycosides (Proctor
et al., 2014). Aminoglycosides have also been shown to select for
the SCV phenotype, as the reduction in the membrane potential
resulting from the disrupted ETC will lower the active transport
necessary for aminoglycosides to cross the membrane (Balwit
et al., 1994). The combination of trimethoprim/sulfamethoxazole
(co-trimoxazole) has been found to select specifically for
thymidine auxotrophic SCVs due to the anti-folate action of
the drug (Garcia et al., 2013). While SCVs have been primarily
studied in Staphylococcus aureus, they have been described
in a number of bacteria including Pseudomonas aeruginosa,
Eacherichia coli, Vibrio cholera, Salmonella, and Lactobacillus
acidophilus (Proctor et al., 2006). Furthermore, they have been
linked to a number of recurrent infections including those caused
by S. aureus (Proctor et al., 1995), P. aeruginosa (Haussler
et al., 1999) and E. coli (Roggenkamp et al., 1998; for a
comprehensive review see: Kahl et al., 2016). Although typically
less virulent due to their slower growth and reduced expression
of virulence factors, such as toxins and lytic enzymes, their ability
to adhere, invade and persist within the host cell increases,
which is thought to be a crucial factor in the ability of SCVs
to cause recurrent or persistent infections (Sendi and Proctor,
2009).
We have previously found that exposure to sub-lethal
concentrations of triclosan with subsequent selection on
gentamicin could generate stable L. monocytogenes SCV cells
(Christensen et al., 2011), which all had mutations in one of
the heme biosynthesis or metabolism genes and exhibited the
same traits observed in SCVs of other species (e.g., colony size,
decreased haemolytic activity, aminoglycoside resistance and
altered carbon utilization). Our SCV E18 strain also showed
reduced growth typical of SCVs from other species, taking
roughly four more hours to reach the same maximal cell density
as the wild type strain (∼109 CFU/ml), however, we also observed
a sensitivity to aerated growth conditions (Kastbjerg et al., 2014),
which to our knowledge has not been shown in SCVs from other
species.
The phenotypic switching of the SCV and the persister cell
are thought to be part of a bacterial bet-hedging strategy,
allowing a small percentage of the population to survive and
repopulate following stress exposure (Sousa et al., 2012). These
two phenotypes share a number of other characteristics including
slowed growth, intracellular persistence and a link to chronic
infections. Thus, given these similarities, we speculate that
a stable L. monocytogenes heme deficient SCV would show
a similar tolerance toward a broad range of antibiotics that
persister cells do. Furthermore, we sought to determine if
L. monocytogenes SCVs are better at invading and surviving
intracellularly, as they have been shown to in S. aureus (Sendi
and Proctor, 2009). Taken together, these results will help to
determine the clinical significance of Small Colony Variants in
L. monocytogenes.
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MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Listeria monocytogenes strain N53-1 and a mutant thereof (E18)
were included in the present study. N53-1 represents a food-
processing plant persistent molecular subtype and was isolated
from a fish smokehouse (Wulff et al., 2006). Strain E18 [denoted
as strain (1) 1-1 in Christensen et al. (2011)] is a stable SCV
of N53-1, with a Single Nucleotide Polymorphism (SNP) in the
glutamyl tRNA reductase (hemA) gene (Kastbjerg et al., 2014),
generated through an adaptive evolution experiment where N53-
1 was exposed to sub-lethal levels of triclosan and subsequently
selected on gentamicin (Christensen et al., 2011). Strains were
stored at−80◦C and grown on Brain Heart Infusion (BHI; Oxoid
CM 1135) agar at 37◦C for 24 h. Overnight cultures were achieved
by inoculating single colonies in 10 ml of BHI broth (Oxoid CM
1135) and incubating at 37◦C with shaking at 250 rpm.
Preparation of Antibacterial Agents
Fresh antibiotic solutions were prepared for each experiment:
ampicillin (dissolved in sterile MilliQ water; Sigma–Aldrich
A9518), erythromycin (dissolved in 96% ethanol; Sigma–Aldrich
E6376), gentamicin (dissolved in sterile MilliQ water; Sigma–
Aldrich G3632), norfloxacin (dissolved in sterile MilliQ with
1% glacial acetic acid; Fluka N9890) vancomycin (dissolved in
sterile MilliQ; Sigma–Aldrich V2002) and co-trimoxazole, which
is comprised of one part trimethoprim (dissolved in sterile MilliQ
with 1% glacial acetic acid; Sigma–Aldrich 92131) and five parts
sulphamethoxazole (dissolved in acetone; Fluka S7507). H2O2
(30% in water; Sigma–Aldrich 216763) was diluted to 20 mM in
sterile MilliQ water.
Minimal Inhibitory Concentration (MIC)
Assay
Antibiotic MIC values were determined in BHI broth as
previously described (Cockerill et al., 2012). In brief, stationary
phase cultures of N53-1 and SCV E18 were adjusted to
OD600 = 0.2 and further diluted 1000-fold, corresponding
to a CFU/ml of 105. The adjusted cultures were tested
against norfloxacin, ampicillin, gentamicin, and co-trimoxazole
(trimethoprim/sulfamethoxazole) using a twofold dilution series
of concentrations ranging from 100 to 0.10 µg/ml in 96-well
plates (Thermo Scientific 163320) and incubated at 37◦C. MIC
for N53-1 and SCV E18 was determined by visual inspection after
24 and 48 h of incubation at 37◦C, respectively. Two biological
replicates were performed.
Killing Kinetic Assays
To compare the antibiotic and H2O2 sensitivity of SCV E18 and
N53-1, killing kinetics were performed according to Knudsen
et al. (2013). Overnight cultures were diluted 106-fold in 10 ml
BHI broth and incubated into early stationary phase for 16 h
at 37◦C with shaking at 250 rpm. Each culture was then
adjusted to an optical density at 600 nm (OD600) of 0.2 in
2 ml BHI broth and challenged with antibiotic (30X MIC except
nitrofurantoin, which was 10X MIC) at 37◦C. Bacterial counts
were performed at 0, 4, 10, 24, 48, and 72 h. The antibiotics and
concentrations used were norfloxacin (100 µg/ml), ampicillin
(185 µg/ml), erythromycin (6 µg/ml), vancomycin (47 µg/ml),
and co-trimoxazole (95 µg/ml). Cultures treated with H2O2
were grown and adjusted as described above, then treated with
20 mM and incubated under stagnant conditions at 37◦C for 2 h.
Three independent biological replicates were performed for each
experiment and the limit of detection was 102 CFU/ml.
Anaerobic Culturing Conditions
To verify that E18 was sensitive to oxygen, it, along with N53-
1, were cultured in anaerobic conditions. Oxygen was removed
from the media by autoclaving, followed by incubation in a
HP0011 anaerobic jar (Oxoid) with an anaerobe gas generation
bag (Sigma–Aldrich 68061) for 24 h. Ten microliters of an
overnight culture was added to the anaerobic BHI, along with a
new anaerobe gas generation bag and incubated on the lab bench
for 3 h to allow for an anaerobic atmosphere to be generated
before incubation with shaking. The cultures were grown for 72 h
at 37◦C with shaking at 200 rpm. Two biological replicates were
performed.
hemA Complementation
E18 carries several single nucleotide polymorphisms (SNPs) of
which one is in the hemA gene (Kastbjerg et al., 2014). To
verify the role of the SNP in hemA in the SCV E18 strain, a
hemA complementation strain was constructed. The hemA gene
with a 128 bp upstream region including the native promoter
was amplified from genomic DNA of N53-1 with the forward
primer 5′-AAACTCGAGTCATCCGTTAACTCCTCG and the
reverse primer 5′-AAAGAATTCATAGAAGGAGTTGGAATG
GA, which contained terminal XhoI and EcoRI sites, respectively,
using Phusion High Fidelity DNA Polymerase (NEB, M0530S).
The pSOG30222 plasmid (Hain et al., 2008) and hemA amplicon
were digested with XhoI and EcoRI, and ligated overnight using
a 3:1 insert to vector ratio, then electroporated into 60 µl
of electrocompetent DH5α cells using a MicroPulser (BioRad
165-2100). Transformants were selected on Luria–Bertani plates
with 100 µg/ml erythromycin and verified by colony PCR
and sequencing (GATC Biotech). Plasmids containing the
correct pSOG30222::hemA construct, along with an unmodified
pSOG30222 control plasmid, were transformed into the SCV
E18 strain. Transformants were selected on BHI agar with
5 µg/ml erythromycin and confirmed with colony PCR and
sequencing. With the exception of the killing kinetic assay, all
complementation experiments were carried out in the presence of
5 µg/ml erythromycin. Colony pictures were taken of each strain
with an Olympus BX51 microscope at 40×magnification.
Macrophage Internalization and Survival
Assay
A murine macrophage cell line, RAW 264.7 (Sigma–Aldrich
91062702), was used to test bacterial internalization and
intracellular survival using a protocol adapted from Bateman and
Seed (Bateman and Seed, 2012). RAW 264.7 macrophages were
grown in Dulbecco’s Modified Eagle’s Medium – high glucose
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(Sigma–Aldrich D6546), 10% heat inactivated fetal bovine serum
(Sigma–Aldrich F9665) and L-glutamine (Sigma–Aldrich G7513)
in 150cc tissue culture flasks, for 10–15 passages prior to use.
A cell scraper was used to disjoin the adherent cells from the
surface. RAW 264.7 cells were seeded into 24-well plates at a
density of 2 × 106 cells/ml in RAW 264.7 culture media and
then incubated for a total of 48 h at 37◦C with 5% CO2. During
the 48 h, one group of RAW 264.7 cells was stimulated for 18 h
with 1 ng/ml IFNγ, required for macrophage activation, and a
second group was stimulated with 100 nM phorbol 12-myristate
13-acetate (PMA), a known inducer of nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase activity (Walloschke
et al., 2010) for 2 h, while a third control group was left
unstimulated. Prior to infection, IFNγ and PMA were removed
from the RAW 264.7 containing wells. Overnight cultures of
N53-1 and SCV E18 were diluted 106-fold in 10 ml of BHI
media and grown at 37◦C for 16 h. L. monocytogenes cultures
were adjusted to a density of 2 × 107 CFU/ml in PBS and
added to the confluent RAW 264.7 containing wells, achieving
a multiplicity of infection (MOI) of 10. Plates were centrifuged
for 5 min at 1,000 rpm to synchronize the infection and
incubated at 37◦C for 1 h. The plates were then incubated for
an additional 2 h in media containing 100 µg/ml gentamicin,
which was reduced to 50 µg/ml gentamicin for the remainder
of the incubation. In order to verify that gentamicin did not
favor the resistant SCV E18 during the 21 h incubation step,
a control experiment was performed using the same methods
as the unactivated macrophage experiment, with the exception
that the media with 50 µg/ml gentamicin was substituted with
PBS. To enumerate the surviving L. monocytogenes per well,
RAW 264.7 cells were washed twice with PBS, followed by lysis
with 0.1% Triton-X 100 (Sigma–Aldrich T8787) and then serial
dilutions of the intracellular bacteria were plated on BHI agar
plates. Internalization was measured following 3 h of incubation,
while survival was measured after 24 h.
Statistical Analysis
CFU/ml values for each biological replicate were log10
transformed prior to statistical analysis. For the killing kinetic
and O2 sensitivity assays, significant differences between the
N53-1 and SCV E18 were determined using a paired t-test, where
significance is equal to P < 0.05. Significance between N53-1 and
SCV E18 for the RAW 264.7 internalization and survival assays
was determined using a paired t-test (P < 0.05) with the log10
transformed CFU/ml values. Significance for each strain between
the RAW264.7 treatment groups was calculated using a one-way
ANOVA test for the log10 transformed CFU/ml values, where
P < 0.05 determined significance. Significance between the two
strains within each RAW264.7 treatment group was calculated
using a paired t-test (P < 0.05). The limit of detection for all
CFU/ml values was 102. All data analysis was performed in Excel.
Replicates falling below the detection limit were set to 99 for
statistical analysis.
RESULTS
SCV E18 Shows Increased Tolerance to
Antibiotics
The L. monocytogenes SCVs, selected on gentamicin, were
resistant to other aminoglycosides (Kastbjerg et al., 2014). To
determine if the SCV phenotype conveys resistance to other
antibiotics, MIC values of selected antibiotics were tested for both
N53-1 and SCV E18, which were found to be the same for the two
strains (Table 1).
Because L. monocytogenes SCV grow slower than the wild
type (Kastbjerg et al., 2014), and because of the lowered
oxidative phosphorylation observed in other SCV organisms,
such as S. aureus (Proctor et al., 1998), we hypothesized that
L. monocytogenes SCVs would have an increased tolerance
to other classes of antibiotics, which was evaluated using
time dependent killing experiments. With the exception of
erythromycin, the SCV E18 strain survived significantly better
for each antibiotic challenge up to 48 h (Figure 1; ampicillin,
P = 0.0007; co-trimoxazole, P = 0.02; vancomycin, P = 0.02 and
norfloxacin, P = 0.03), with between one and threefold higher
log10 CFU/ml as compared to the N53-1. When treated with
norfloxacin, both N53-1 and SCV E18 exhibited a biphasic killing
curve with a rapid decline to approximately three and five log10
CFU/ml, respectively, which remained stable throughout the 72 h
experiment (Figure 1A). Ampicillin has a delayed bactericidal
effect on L. monocytogenes (Winslow et al., 1983), which was
also observed with SCV E18, as is evidenced by the roughly
three-fold log10 reduction in CFU/ml over the 48–72 h time
points (Figure 1B). However, this delayed bactericidal effect of
ampicillin was not observed for N53-1 over the course of the
TABLE 1 | Minimum Inhibitory Concentration (MIC) values for Listeria monocytogenes wild type strain N53-1 strain and SCV E18 strain.
MIC µg/ml
Strain Ampicillin Co-trimoxazole Norfloxacin Erythromycin Vancomycin Gentamicin
N53-1 3.13 0.78 3.13 0.20 1.56 0.40
E18 3.13 0.78 3.13 0.20 1.56 12.50
E18
pSOG30222::hemA
1.56 0.78 3.13 – 1.56 0.40
E18 pSOG30222 1.56 0.78 3.13 – 1.56 12.50
The MIC assay was performed using BHI broth and incubated at 37◦C for 24 and 48 h for N53-1 and SCV E18, respectively. All experiments were done with two
independent replicates. – , not tested.
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FIGURE 1 | Killing of Listeria monocytogenes N53-1 () and SCV E18 (©) over the course of 72 h under shaking conditions with (A) norfloxacin, (B)
ampicillin, (C) co-trimoxazole, (D) vancomycin, and (E) erythromycin. Error bars represent standard deviation of the mean for three biological replicates.
Significance at the 48-h time point was determined using a paired t-test (∗p < 0.05 and ∗∗p < 0.005).
72 h killing kinetic (Figure 1B). By the end of the 72 h treatment
with co-trimoxazole, SCV E18 decreased in a linear manner
to a comparable level with N53-1 (2.3 × 105 and 5.6 × 104
CFU/ml, respectively; P = 0.45; Figure 1C). Vancomycin had
an initial bacteriostatic effect on both strains, followed by linear
killing, however, the bactericidal effect began earlier for N53-1
(T = 10), while the SCV E18 strain resisted killing until the 24 h
time point (Figure 1D). Erythromycin was bacteriostatic on both
strains up to the 48 h time point, however, bacterial counts for
SCV E18 decreased after 48 h, while the N53-1 remained stable
(Figure 1E).
While the SCV phenotype in L. monocytogenes does not confer
notable resistance to antibiotics besides the aminoglycosides, they
survived significantly better under high antibiotic concentrations
for up to 48 h under ampicillin or co-trimoxazole, and up to 72 h
when exposed to norfloxacin or vancomycin. In contrast, by 72 h
of exposure to erythromycin or ampicillin, the SCV has fewer
CFU/ml than the wild type.
Oxygen Sensitivity, But H2O2 Resistance,
of the SCV E18
When grown under shaking conditions, SCV E18 grows to a
maximum density of approximately 1 × 109 CFU/ml after 12 h,
where after the CFU/ml decreases rapidly, eventually dropping
below the limit of detection after 24 h (Kastbjerg et al., 2014).
Here, we grew cultures of the SCV E18, along with the N53-1,
anaerobically to test if the observed decrease in CFU/ml is caused
by exposure to oxygen. When grown anaerobically, cultures of
the SCV E18 grow to higher densities (8.1 × 108 CFU/ml) after
72 h, than the N53-1 strain (2.5 × 108 CFU/ml; P = 0.002)
(Table 2), suggesting that oxygen is toxic to the SCV E18 strain.
Under anaerobic growth conditions the SCV E18 strain retained
the pin point colony morphology when plated, whereas the N53-1
strain exhibited variable colony size.
To test if the oxygen sensitivity was related to a general
deficiency in the oxidative stress response, such as the absence
of catalase in the SCV E18, we treated with 20 mM H2O2
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TABLE 2 | Oxidative stress sensitivity of L. monocytogenes N53-1 and SCV E18 as measured by aerobic and anaerobic growth, and exposure to 20 mM
H2O2 for 2 h.
Bacterial count (Log10 CFU/ml)
Growth in BHI for 72 h Survival in 20 mM H2O2
Aerobic Anaerobic 0 h 2 h
N53-1 9.4 ± .01 8.4 ± 0.03 7.2 ± 0.04 3.7 ± 0.09
E18 BD 8.9 ± 0.02 7.2 ± 0.13 6.3 ± 1.02
E18 pSOG30222::hemA 8.1 ± 0.09 – 8.0 ± 0.22 5.2 ± 0.17
E18 pSOG30222 BD – 8.0 ± 0.06 6.5 ± 0.41
All experiments are log10 CFU/ml mean values of three biological replicates ± standard deviation. BD, below the limit of detection; –, not tested.
for 2 h. Surprisingly, the SCV E18 survived significantly better
(P = 0.008) than the wild type, with the number of colony
forming bacteria following treatment being 33% of the inoculum,
whereas the N53-1 strain survived at a rate of 0.03% (Table 2).
Thus, similar to the increased tolerance toward antibiotics, and
regardless of the oxygen sensitivity and lack of catalase (Kastbjerg
et al., 2014), the SCV E18 strain exhibits a greater ability to resist
killing by H2O2 over the wild type.
hemA Complementation Restores Wild
Type Phenotype of SCV E18
By genome sequencing and analyses, we previously demonstrated
that all of the L. monocytogenes SCVs had several mutations,
including a mutation in the hemA gene (Kastbjerg et al., 2014).
To determine if the tested aspects of the SCV phenotype were due
to the SNP in the hemA gene, a wild type hemA complemented
strain of E18 was constructed. This complemented strain
regained the large colony phenotype (Figure 2A), had restored
gentamicin sensitivity identical to the N53-1 strain (Table 1),
regained sensitivity to H2O2 and lost its sensitivity to oxygen, as
demonstrated by the presence of viable colonies after culturing
for 72 h (Table 2). Furthermore, the level of antibiotic tolerance
was evaluated with a time dependent killing experiment using
norfloxacin. The killing curve of the complemented hemA
strain was significantly different from the empty vector control
(P = 0.0000046), and was similar to the killing of N53-1 strain,
while the empty vector control showed a very similar curve to its
non-transformed counterpart SCV E18 (Figure 2B).
SCV E18 Is Less Affected by Macrophage
Status Than Wild Type N53-1
We investigated the survival ability of the wild type and the SCV
E18 in the IFNγ activated and un-stimulated macrophage model.
Additionally, due to the increased tolerance of SCV E18 toward
H2O2, we used macrophages stimulated with PMA, a known
activator of the NADPH oxidase pathway. Three hours following
infection of the un-stimulated macrophage there was a high
degree of internalization and intracellular growth of N53-1 and
SCV E18, with 7.6 log10 CFU/ml and 7.5 log10 CFU/ml recovered,
respectively, a difference that was not statistically significant
(P = 0.77). These internalization findings were similar for the
other two treatment groups (Figure 3A). By 24 h of incubation in
FIGURE 2 | hemA complementation experiments showing (A) colony
morphology at 40x magnification of I: N53-1, II: SCV E18, III: E18
pSOG30222, and IV: E18 pSOG30222::hemA after 24 h of incubation at
37◦C on BHI plates and (B) Killing of L. monocytogenes N53-1 () and
SCV E18 (©) strains, as well as the hemA complemented ( ) and
empty vector control E18 (H#) strains exposed to 100 µg/ml norfloxacin
for 72 h. The data represents three biological replicates with standard
deviation of the mean. Significance was determined using a paired t-test
(∗∗∗p < 0.000005).
the un-stimulated macrophage, bacterial counts were drastically
reduced for both strains, although N53-1 survived significantly
better (P = 0.006) with 3.6 log10 CFU/ml of the N53-1 and 2.3
log10 CFU/ml for SCV E18 (Figure 3B). When macrophages
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FIGURE 3 | Intracellular (A) internalization and (B) survival of
L. monocytogenes N53-1 and SCV E18 in RAW264.7 cells treated with
IFNγ, PMA and no treatment using a multiplicity of infection (MOI) of
10. Bacterial counts for the internalization assay were determined after 2 h of
100 µg/ml gentamicin exposure. Survival was determined after 21 additional
hours of incubation with 50 µg/ml gentamicin. Values are displayed as the
log10 transformed mean of three biological replicates with standard deviation.
Significance was determined using a paired t-test (∗p < 0.05).
were activated with IFNγ, the survival difference between strains
vanished, as the number of recovered N53-1 bacteria at 24 h
was reduced to 2.06 log10 CFU/ml, while the SCV E18 burden
was almost unchanged by IFNγ activation (2.15 log10 CFU/ml)
(Figure 3B). Increased reactive oxygen species (ROS) production,
via PMA activation of the NADPH oxidase pathway, resulted in
a slight, but significantly higher bacterial burden of macrophages
infected with SCV E18 (2.7 log10 CFU/ml), than N53-1 (2.1 log10
CFU/ml; P= 0.02) (Figure 3B). While activation of macrophages
with IFNγ or stimulation with PMA significantly reduced the
intracellular bacterial load of N53-1 (P = 0.01), the SCV E18 was
not sensitive to either treatment and remained unchanged across
groups (P = 0.17).
To summarize, macrophages were equally poor at controlling
the bacterial burden of both N53-1 and SCV E18 in the short
term (T = 3 h), however, by 24 h the CFU/ml for all intracellular
bacteria had been severely reduced. While survival in the un-
activated macrophage was attenuated for SCV E18, as compared
to N53-1, it was unaffected by the status of the macrophage
unlike N53-1, which was significantly reduced in CFU/ml upon
macrophage activation with IFNγ or stimulation with PMA.
DISCUSSION
The Small Colony Variant (SCV) has been described for decades
in several bacteria such as S. aureus, E. coli and P. aeruginosa
(Proctor et al., 2006). However, they were only recently identified
in L. monocytogenes and, with the exception of aminoglycoside
resistance (Kastbjerg et al., 2014), their importance with respect
to the treatment of listeriosis has not been investigated. This
study is the first to demonstrate that the SCV phenotype of
L. monocytogenes caused by a single point mutation in the
hemA gene has the potential to complicate treatment by causing
an increase in tolerance toward most of the clinically relevant
antibiotics.
As shown previously (Kastbjerg et al., 2014), SCV E18
exhibited resistance to the aminoglycoside gentamicin, a defining
trait of the electron-transport deficient SCV (Proctor et al., 2006).
This is particularly relevant for listeriosis, as gentamicin is the
most common secondary antibiotic used for treatment (Temple
and Nahata, 2000). While the SCV E18 showed no increase in
MIC for the other antibiotics tested, indicating a lack of acquired
resistance, it was nonetheless able to survive lethal concentrations
of norfloxacin, ampicillin (up to 48 h), co-trimoxazole, and
vancomycin significantly better than the wild type, which taken
together, are the definition of antibiotic tolerance (Dimitrijovski
et al., 2015). The increase in tolerance toward vancomycin,
second generation fluoroquinolones (e.g., norfloxacin) and beta-
lactams (e.g., ampicillin) has been observed with S. aureus
SCVs and is presumably the result of their slow growing SCV
phenotype (Chuard et al., 1997; Garcia et al., 2012; Lechner
et al., 2012). Antibiotic tolerance poses a unique clinical dilemma,
as any testing on isolates relying solely on MIC values could
obscure the true antimicrobial susceptibility of the SCV and lead
to sub-optimal treatment strategies.
In contrast to the other antibiotics, SCV E18 did not survive
better under erythromycin pressure at any time point during the
experiment and, as with ampicillin, became more sensitive after
48 h of killing. This could indicate that whatever protective effect
the SCV phenotype contributes toward other antibiotics does
not apply to the macrolide class, which target protein synthesis.
Interestingly, S. aureus SCVs were not isolated from cystic fibrosis
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patients treated exclusively with the macrolide azithromycin,
whereas when treated with other antibiotics, SCVs were observed
in 46% of patients colonized with S. aureus (Kahl et al., 2003;
Green et al., 2011). Although the SCV L. monocytogenes E18
tolerates ampicillin better than the wild type N53-1 in the short
term, the sensitivity toward extended exposure (as evidenced
by the pronounced decrease in bacterial count following 48 h
of treatment) and the fact that long-term (between 2 and
8 weeks) ampicillin therapy is the primary treatment of choice
for listeriosis (Temple and Nahata, 2000), could explain why
the SCV phenotype has, to our knowledge, not been observed
in in clinical cases. However, it is also possible that current
screening procedures in the clinical laboratory are inadequate,
leading the SCV sub-population to go unnoticed (Proctor et al.,
2006). The slower growth of SCV E18 would likely cause it to
be overshadowed in a mixed culture containing the wild type.
Furthermore, the altered sugar metabolism and lack of catalase
observed in SCV E18 (Kastbjerg et al., 2014), as well as the fact
that some of the media used to grow L. monocytogenes contain the
compounds SCVs are auxotrophic for, would complicate proper
identification of any SCV L. monocytogenes clinical isolates.
We were expecting the SCV E18 to be more sensitive to H2O2
because it does not produce catalase, however, it was able to
better withstand H2O2 than the wild type. As H2O2 reacts with
the heme cofactor of proteins (Nagababu and Rifkind, 1998), our
observation may simply be the result of fewer targets in the heme
deficient SCV E18. Alternatively, tolerance toward H2O2 may
be due to a change in the metabolism of the SCV, as suggested
by Painter et al. (2015). In addition to showing that heme
auxotrophic SCVs of S. aureus were more tolerant of H2O2, they
added 4-hydroxy-2-heptylquinoline-N-oxide (HQNO), which
can induce the SCV phenotype by blocking the electron transport
chain of Gram-positive bacteria, to wild type S. aureus either
hours or minutes before exposure to lethal levels of H2O2. Those
bacteria grown for hours in the presence of HQNO survived the
H2O2 exposure significantly better than the wild type, whereas
those that received the HQNO only minutes before did not.
This demonstrates that the tolerance is not simply the result of
reduced electron transport, but as the authors suggest, a global
physiological change caused by the loss of the electron transport
chain (e.g., a switch to anaerobic metabolism), which could also
explain our similar observation in L. monocytogenes.
In addition to the typical characteristics of the SCV,
L. monocytogenes SCVs exhibit a unique sensitivity to growth
under shaking conditions as they enter the stationary phase
(Kastbjerg et al., 2014). Here, we demonstrate that this results
from the presence of oxygen in the media. The addition of
catalase, which converts H2O2 to water and oxygen, or heme
(necessary for the biosynthesis of catalase) to the growth media
abolished this effect, suggesting that the oxygen sensitivity is due
to the inability of the heme-deficient SCV mutant to produce
catalase (Kastbjerg et al., 2014). However, to our knowledge, this
oxygen sensitivity has not been observed in heme-deficient SCVs
of other catalase-dependent species (Roggenkamp et al., 1998;
Zahra et al., 2013), and this fails to explain why the associated
toxicity only manifests in the stationary phase. Few explanations
seem to coincide with the observed increased tolerance toward
H2O2 and extended viability of SCV E18 cells when treated with
antibiotics, however, we believe this is an important observation
that warrants further research.
When the wild type and SCV E18 were inoculated with
RAW264.7 murine macrophages over the course of 3 h, we
observed no difference between the internalization of the
two strains. However, prolonged incubation of the infected
macrophages revealed differences between the fates of each strain
depending on the activation status of the macrophages. N53-1
survived better than SCV E18 in the naïve macrophages, however,
this difference disappeared once macrophages were activated
with IFNγ where the wild type was reduced to the same CFU/ml
as the mutant. The former observation is likely explained by
the reduced expression of the pore-forming toxin Listeriolysin O
(LLO) (Kastbjerg et al., 2014) in SCV E18, which has been shown
to be produced in murine macrophages (Moors et al., 1999) and
is necessary for L. monocytogenes to escape from the phagosome
(Bielecki et al., 1990). The latter observation corresponds with
studies showing that IFNγ-activated macrophages are able to
block the escape of L. monocytogenes (Portnoy et al., 1989) by a
process thought to be mediated by ROS inactivation of the LLO
toxin (Myers et al., 2003). This suggests that macrophages need
not first be activated by IFNγ in order to control L. monocytogenes
SCVs, which contrasts to SCVs from other species, and could
explain the lack of observed clinical L. monocytogenes SCVs.
On the other hand, LLO is the most immunogenic antigen for
the T cell response, which mediates the ultimate removal and
adaptive immunity to L. monocytogenes (Vijh and Pamer, 1997),
thus a reduction in LLO expression may lead to a weaker adaptive
immune response to SCV E18 and could explain the observation
that mutants incapable of producing LLO persist for significantly
longer in the bone marrow of infected mice (Hardy et al., 2009).
Furthermore, the PMA stimulated macrophage showed that SCV
E18 is significantly better at surviving the bactericidal effects
of ROS within the phagosome, which is consistent with its
observed increase in H2O2 tolerance, and could have implications
on the fate of SCV L. monocytogenes in neutrophils that rely
predominantly on NADPH oxidase for their bactericidal activity
(Segal, 2005).
Our complementation experiment showed that this phenotype
can arise through a single base-pair substitution in the hemA
gene, and given the prevalence of verified SCV selection pressures
L. monocytogenes faces both in the environment and during
treatment (e.g., triclosan, gentamicin and co-trimoxazole), the
probability of exposure to SCV L. monocytogenes seems high.
Therefore, it is surprising that no clinical cases of SCV associated
listeriosis have been reported. Perhaps the long treatment with
ampicillin is enough to eradicate the SCV, or the immune system
is better able to control SCV L. monocytogenes, as indicated
by our findings with non-IFNγ activated RAW264.7 murine
macrophages. However, it seems equally likely that this elusive
phenotype has gone unnoticed due to a lack of adequate screening
procedures in clinical laboratories.
Much like persister cells, SCVs have also been shown
to revert to the wildtype phenotype. When clinical and
laboratory strains of S. aureus were cyclically grown with and
without gentamicin, an identical proportion of SCVs upon each
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exposure to the antibiotic was observed (Massey et al., 2001).
Drenkard and Ausubel (2002) found the same phenotypic
switching in P. aeruginosa, and also identified a protein that
modulates the switch between the wild type and SCV phenotypes.
This phenotypic heterogeneity, often referred to as a bet-hedging
strategy, allows a portion of the bacterial population to survive
a stress (e.g., antibiotic exposure or the phagosome), without
giving up any fitness advantages associated with mutation. It
is plausible that the majority of SCVs in vivo are the result of
phenotypic switching, and although, we observed no reversion
with SCV E18, this mutant and others like it could represent
a small subset of SCVs locked in the on position. This would
add another treatment challenge, as the bacterial population as a
whole would be protected from antibiotics, while simultaneously
capable of full virulence (Tuchscherr et al., 2011). Reports of
SCVs from a variety of bacterial species being linked to persistent
and chronic infections are numerous (Proctor et al., 1995; von Eiff
et al., 1997; Roggenkamp et al., 1998; Seifert et al., 1999; Häussler
et al., 2003), and while uncommon, cases of recurrent listeriosis
have been reported and the cause of these treatment failures were
not determined (McLauchlin et al., 1991; Sauders et al., 2001;
Kleemann et al., 2009).
Although L. monocytogenes SCVs may be unique in that
macrophages are able to control them without first becoming
activated by IFNγ, they may yet be able to better survive
other aspects of the immune system, and the presence of
an easily generated, multi-antibiotic tolerant sub-population
is nonetheless a cause for concern. Awareness and adequate
screening for SCVs in clinical isolates, such as extended
incubation times and inclusion of isolates with non-standard
sugar metabolism or those lacking catalase activity, would also
help to determine the role (if any) this phenotype plays in
human infection with L. monocytogenes, and we believe the
evidence presented here warrants such measures being employed
in clinical laboratories.
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